Martínez F, Sørensen M, Nowak P. "一种的合成方法" [P]. European Patent, EP 3203927 A1, 2019-02-25.
发明人郑宇鹏,林芳,钱学锋. "Method for the Synthesis of N-(5-(2-Chlorophenyl)-1,3,4-oxadiazol-2-yl)-3-morpholinopropanamide" [P]. 中国发明专利, 专利号 CN 110147839 A, 授权公告日 2023-10-07.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2023, 297, (11), 2675-2680.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Food Chem., 2022, 2186, (1), 5672-5693.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of N-(5-(2-Chlorophenyl)-1,3,4-oxadiazol-2-yl)-3-morpholinopropanamide Using HRMS and NMR". Anal. Methods, 2022, 2363, (4), 4707-4713.
Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2013, 758, (2), 3865-3881.